尼莫利祖马布在结节炎中长达100周:奥林匹亚LTE中间分析
Franz J Legat1, Shawn G Kwatra2,3, Adam Reich4
1Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
长期治疗 Prurigo nodularis (PN) 的尼莫利祖马布,表现出良好的耐受性和显著的症状控制. 患者在,皮肤病变和生活质量方面经历了显著改善.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 结 (PN) 是一种慢性神经免疫性皮肤疾病,引起强烈的和皮肤病变.
- 目前的治疗方法旨在控制症状并改善患者的生活质量.
研究的目的:
- 评估纳莫利祖马布在中度至重度PN的成年人中长期的安全性和疗效.
- 在OLYMPIA-LTE试验中,Nemolizumab在184周的时间内进行了评估.
主要方法:
- 从先前的试验中加入了中度至重度PN的成年人.
- 患者接受了连续的尼莫利祖马布或开始治疗,如果以前接受安慰剂.
- 关键的疗效终点包括减少 (PP-NRS4),改善睡眠 (SD-NRS4),改善生活质量 (DLQI4) 和病变愈合.
主要成果:
- 超过57%的患者完成了100周的治疗.
- 治疗引起的不良事件大多为轻度/中度,COVID-19和上呼吸道感染是常见的.
- 在第100周观察到高疗效率:92%实现PP-NRS4,86%SD-NRS4,91%DLQI4,74%IGA 0/1,84%>75%的病变愈合.
结论:
- 在PN患者中,长期的尼莫利祖马布治疗耐受性很好.
- 尼莫利祖马布有效控制PN,导致,皮肤病变和生活质量的显著改善.
更多相关视频
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Treatment Resistant Cancers
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
